Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

Cliona M. Rooney; C.M Rooney; Catherine Y. Ng; Susan K. Loftin; Colton A. Smith; C Li; Robert A. Krance; Malcolm K. Brenner; H.E Heslop; Cliona M. Rooney; C.M Rooney; Malcolm K. Brenner; Malcolm K. Brenner; Robert A. Krance; H.E Heslop

doi:10.1016/s0140-6736(95)91150-2

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

Cliona M. Rooney(St. Jude Children's Research Hospital), C.M Rooney(St. Jude Children's Research Hospital), Catherine Y. Ng(St. Jude Children's Research Hospital), Susan K. Loftin(St. Jude Children's Research Hospital), Colton A. Smith(St. Jude Children's Research Hospital), C Li(St. Jude Children's Research Hospital), Robert A. Krance(St. Jude Children's Research Hospital), Malcolm K. Brenner(St. Jude Children's Research Hospital), H.E Heslop(St. Jude Children's Research Hospital), Cliona M. Rooney(St. Jude Children's Research Hospital), C.M Rooney(St. Jude Children's Research Hospital), Malcolm K. Brenner(St. Jude Children's Research Hospital), Malcolm K. Brenner(St. Jude Children's Research Hospital), Robert A. Krance(St. Jude Children's Research Hospital), H.E Heslop(St. Jude Children's Research Hospital)

The Lancet

January 1, 1995

10.1016/s0140-6736(95)91150-2

Cited by 1,201

Abstract

Related Papers

No related papers found

Powered by citation graph analysis